Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 31,036 |
|
|||||
| News | - | ||||||
| Day High | 4.40 | Low High |
|||||
| Day Low | 4.26 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cardiff Oncology Inc | CRDF | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0698 | -1.60% | 4.3002 | 08:45:37 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.38 | 4.26 | 4.40 | 4.37 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 212 | 31,036 | US$ 4.32 | US$ 134,075 | - | 0.94 - 6.42 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:46:25 | 2 | US$ 4.31 | USD |
Cardiff Oncology (CRDF) Options Flow Summary
Cardiff Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 53.17M | 44.68M | - | 488k | -41.47M | -0.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cardiff Oncology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.62 | 5.86 | 4.20 | 4.78 | 1,062,759 | -1.32 | -23.48% |
| 1 Month | 5.13 | 6.42 | 4.20 | 5.49 | 1,210,496 | -0.8298 | -16.18% |
| 3 Months | 1.48 | 6.42 | 1.44 | 3.82 | 1,955,740 | 2.82 | 190.55% |
| 6 Months | 1.14 | 6.42 | 0.94 | 3.58 | 1,000,771 | 3.16 | 277.21% |
| 1 Year | 1.48 | 6.42 | 0.94 | 2.88 | 810,875 | 2.82 | 190.55% |
| 3 Years | 8.24 | 10.24 | 0.94 | 3.79 | 729,899 | -3.94 | -47.81% |
| 5 Years | 3.43 | 25.50 | 0.701 | 5.80 | 862,798 | 0.8702 | 25.37% |
Cardiff Oncology Description
| Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. |
